Reference
Pujades-Rodriguez M, et al. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLOS One : 3 Dec 2020. Available from: URL: https://doi.org/10.1371/journal.pmed.1003432
Rights and permissions
About this article
Cite this article
Increased CVD risk even with low oral glucocorticoid doses. Reactions Weekly 1835, 6 (2020). https://doi.org/10.1007/s40278-020-87450-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-87450-0